Table 3.

Molecular responses of chronic phase-chronic myeloid leukemia patients treated with a 3^rd tyrosine kinase inhibitor.

Time	RQ-PCR (IS)%	N	%
Baseline	>10	11/18	61
	1 – 10	04/18	22
	0.1 – 1<	03/18	17
	≤0.1	0	0
3 months	>10	09/12	75
	1 – 10	02/12	17
	0.1 – 1<	0	0
	≤0.1	1/12	08
6 months	>10	04/08	50
	1 – 10	01/08	12.5
	0.1 – 1<	01/08	12.5
	≤0.1	02/08	25